文献速递区域麻醉与超声心胸血管麻醉

脂质体布比卡因胸椎旁阻滞对VATS术后镇痛效果的随机对照试验

Effect of liposomal bupivacaine thoracic paravertebral block on postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery: a randomized controlled trial.
PubMed 文献 · Reg Anesth Pain Med · 2026-03-23

本研究为随机对照试验,纳入93例拟行电视辅助胸腔镜手术(VATS)的成人患者,随机分为脂质体布比卡因(LB)组和布比卡因联合地塞米松(BD)组各39例。主要结局为镇痛持续时间,LB组显著长于BD组(1160.4±403.8 min vs 743.1±216.8 min,p<0.001),平均延长417分钟(56%)。LB组术后第一天静息和咳嗽NRS评分更低,探索性分析显示阿片类药物消耗更少、下床和排气更早、满意度更高。

要点

  • LB胸椎旁阻滞较BD显著延长VATS术后镇痛时间约417分钟。
  • LB组术后第一天静息和咳嗽疼痛评分更低。
  • LB组术后第一天累积羟考酮消耗数值更低,下床和排气更早。

核心结论

  • 在VATS患者行胸椎旁阻滞时,LB较BD显著延长术后镇痛持续时间。
  • 探索性次要结局提示LB在早期疼痛、阿片节俭和早期恢复方面有适度改善。

研究设计与样本

  • 随机对照试验,93例受试者中78例随机分组,LB组和BD组各39例。
  • 研究对象为拟行VATS的成人患者。

主要发现

  • LB组镇痛持续时间1160.4±403.8 min,BD组743.1±216.8 min,p<0.001,平均延长417分钟(56%)。
  • LB组术后第一天静息和咳嗽NRS评分更低,静息痛和咳嗽痛72小时曲线下面积分别为67.5 vs 87.9和213.9 vs 244.0。
  • 探索性分析中LB组术后第一天累积羟考酮消耗数值更低,首次下床和首次排气时间更早,满意度评分更高。
  • 两组术中舒芬太尼总消耗量、住院时间和不良事件发生率无显著差异。

临床怎么用

  • 对于VATS患者,可考虑使用LB行胸椎旁阻滞以延长术后镇痛时间。
  • LB可能有助于减少术后早期阿片类药物消耗并促进早期恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic paravertebral block (TPVB) can provide effective analgesia for patients undergoing video-assisted thoracoscopic surgery (VATS). However, the duration of analgesia achieved with conventional local anesthetics combined with dexamethasone remains limited. This study aimed to determine if liposomal bupivacaine (LB) is superior to bupivacaine combined with dexamethasone (BD) with respect to duration of postoperative analgesia in VATS patients. METHODS: Adults scheduled for VATS were randomized to treatment with LB or BD. The primary outcome was duration of analgesia. Secondary outcomes involved Numeric Rating Scale (NRS) pain scores, cumulative oxycodone consumption, total intraoperative sufentanil consumption, first times to ambulation and flatus, length of hospital stay, patient satisfaction level, and incidence of adverse reactions. RESULTS: Of 93 total subjects, 78 were randomized into two groups (n=39 each). The LB group demonstrated a significantly prolonged duration of analgesia compared with the BD group (1160.4±403.8 min vs 743.1±216.8 min, p<0.001), with a mean increase of 417 min (a 56% extension). LB was associated with lower resting and cough NRS pain scores on the first postoperative day. The 72-hour area under the curve values for scores for resting pain (67.5 vs 87.9) and pain during cough (213.9 vs 244.0) were lower for the LB group versus the BD group. In exploratory analyses, cumulative oxycodone consumption on the first postoperative day was numerically lower in the LB group. Subjects receiving treatment LB had lower cumulative oxycodone consumption on the first postoperative day, earlier times to first ambulation and first flatus, and higher satisfaction scores as compared with subjects receiving BD. There was no significant difference between the two groups in terms of total intraoperative sufentanil consumption, duration of hospital stay, or incidence of adverse events. CONCLUSION: In VATS patients receiving TPVB, LB significantly prolonged the duration of postoperative analgesia compared with BD. Exploratory secondary outcomes suggested modest improvements in early pain profiles and potential opioid-sparing and early recovery benefits. TRIAL REGISTRATION NUMBER: ChiCTR2500095090.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Li J, Li YT, Tang L, et al. Effect of liposomal bupivacaine thoracic paravertebral block on postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery: a randomized controlled trial. Reg Anesth Pain Med. 2026. PMID: 41871916. doi:10.1136/rapm-2025-107478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。